Somatostatin-dopamine chimeric analogs
US7517853B2 · kind B2 · utility
17Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 8, 2004 |
| Grant date | Apr 14, 2009 |
| Priority date | — |
| Expiry date | May 4, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features somatostatin-dopamine chimeric analogs and methods relating to their therapeutic use for the treatment of neoplasia, acromegaly, and other conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.